Development and characterization of a WEHI-3B D+ monomyelocytic leukemia cell line resistant to novobiocin and cross-resistant to other topoisomerase II-targeted drugs.

Source:http://linkedlifedata.com/resource/pubmed/id/1316227

Cancer Res. 1992 May 15 52 10 2782-90

Download in:

View as

Triples

General Info

PMID
1316227